1. The primary tumor was located at postero-superior wall of the nasopharynx in 6 cases and at lateral wall in 5 cases.
2. According to TNM Classification, the tumor was classified as TI in 1 case, T2 in 4 cases , T3 in 3 cases and T4 in 3 cases.
According to Stage Grouping, the tumor was grouped as stage III in 2 cases and stage IV in 9 cases.
3. Clinical results were the following : Response rate was 82%, CR being noted in 1 case and PR in 8 cases for primary lesion. It was 70%, CR in 1 case and PR in 6 cases for lymphnode involvement.
4. 4 patients died of primary lesion and 1 patient, of distant metastasis and 1 patient, of complications. 5-year cumurative survival rate was 45. 5%.
5. This treatment was effective on nasopharyngeal carcinoma up to stage IV, except for T4. 
